Dialyzability of lamotrigine by continuous venovenous haemodiafiltration

Clin Toxicol (Phila). 2022 Feb;60(2):267. doi: 10.1080/15563650.2021.1916517. Epub 2021 May 4.

Authors

Kulanka Premachandra^{1

2}, Shweta Priyadarshini³, Darren Roberts^{1

2}

Affiliations

¹ Saint Vincent's Hospital Sydney, Clinical Pharmacology and Toxicology, Darlinghurst, Australia.
² St Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia.
³ Intensive Care Unit, Saint Vincent's and Mater Health Sydney, Darlinghurst, Australia.

PMID: 33945365
DOI: 10.1080/15563650.2021.1916517

No abstract available

Publication types

Letter

MeSH terms

Acute Kidney Injury* / therapy
Continuous Renal Replacement Therapy*
Critical Illness / therapy
Hemodiafiltration*
Hemofiltration*
Humans
Lamotrigine

Substances

Lamotrigine